Kelly Swinney

Kelly Swinney is a Senior Director at Vertex Pharmaceuticals. She is the Drug Product Continuous Manufacturing Lead and also heads the PAT group supporting API and DP. In her role, Kelly is responsible for Vertex CM strategy development, budgets, partner alliances, cross functional team leadership, and participation in Vertex interactions with regulatory agencies. Her PAT team’s focus is control strategy development and implementation including IPCs and RTRT, PAT method and chemometric model development and validation, and GMP manufacture support.